38 results
Page 2 of 2
6-K
kurr92vtsb
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
lk0x0bsk4
30 Nov 22
Current report (foreign)
6:28am
6-K
EX-99.1
uqz64z318gilah9018gi
27 Oct 22
Current report (foreign)
6:01am
6-K
EX-99.1
9ctj8fnan2u6kwc wr3p
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
040d2 zj06nuthk
28 Jul 22
Current report (foreign)
6:09am
6-K
mipfze
11 Jul 22
Current report (foreign)
6:05am
6-K
EX-99.1
e98x8txm
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
eurc155jc04qkn2tof
31 May 22
Current report (foreign)
6:07am
6-K
j7qhwfy1i7
1 Nov 21
Current report (foreign)
6:04am
6-K
ugehwixq
19 Jul 21
Current report (foreign)
6:02am
6-K
EX-99.1
l4bs9gqgpxmrotwa
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
86p8 2j15rlkr0qo66
28 May 21
Current report (foreign)
6:01am
6-K
43nym5mr7 amqq375w1
11 May 21
Current report (foreign)
6:08am
6-K
EX-99.1
hg1hcw3m
17 Dec 20
Current report (foreign)
6:01am
6-K
i1z7wmy5ryq i7ns
14 Jan 20
Current report (foreign)
6:56am
6-K
EX-99.1
18ps35t 57d9rkcril
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am